⚕️ Licensed pharmacy — prescription medicines are shipped only after our pharmacist verifies your prescription🚚 Free Delivery Nationwide on Orders Rs. 5000+ | Cash on Delivery Available🛡️ 100% Authentic & Licensed – Sourced Directly from Global Brands💊 Got a Prescription? Upload & Get Medicine Delivered to Your Door Whatsapp Us🏆 14,000+ Skincare Products in Stock — Pakistan's #1 Online Pharmacy🚚 A Rs. 49 delivery surcharge applies to all orders⚕️ Licensed pharmacy — prescription medicines are shipped only after our pharmacist verifies your prescription🚚 Free Delivery Nationwide on Orders Rs. 5000+ | Cash on Delivery Available🛡️ 100% Authentic & Licensed – Sourced Directly from Global Brands💊 Got a Prescription? Upload & Get Medicine Delivered to Your Door Whatsapp Us🏆 14,000+ Skincare Products in Stock — Pakistan's #1 Online Pharmacy🚚 A Rs. 49 delivery surcharge applies to all orders
Home › Admit 50/500mg Tablets – Type 2 Diabetes Control
Admit 50/500mg Tablets – Type 2 Diabetes Control
Admit 50/500mg Tablets – Type 2 Diabetes Control photo 1Admit 50/500mg Tablets – Type 2 Diabetes Control photo 2

Admit 50/500mg Tablets – Type 2 Diabetes Control

Rs. 450

Pay in 3 Installments of

Rs.

172

1
100% authentic Dermatologist recommended Licensed pharmacy Buyer’s choice
We accept JazzCashJazzCash easypaisaeasypaisa NayaPayNayaPay Visa baadmay Bank AL HabibBank transfer Cash on Delivery
AvailabilityIn stock
SKUDER0000003367
Share
Description

Admit Tablets 50/500mg – Dual Action Sitagliptin & Metformin Formula for Type 2 Diabetes

Admit Tablets 50/500mg contain Sitagliptin (50mg) and Metformin (500mg), two powerful anti-diabetic medicines that work together to manage Type 2 diabetes mellitus effectively. This combination is designed for patients whose blood sugar is not controlled by diet and exercise alone. Prescription required.

Sitagliptin is a DPP-4 inhibitor that helps the body increase insulin production and decrease glucose production when blood sugar levels are high. Metformin reduces glucose production in the liver and improves insulin sensitivity, allowing better sugar utilisation by the body.

Together, these two ingredients provide comprehensive blood sugar control, lowering both fasting and postprandial glucose levels as part of a complete diabetes management plan.

Browse our full range in the Anti-Diabetic collection and General Medicines at Derma.pk — nationwide delivery across Pakistan.

How to Order Admit 50/500mg Tablets at Derma.pk

At Derma.pk, we ensure the authenticity of Admit Tablets 50/500mg, verified by licensed pharmacists. Delivery is available across Pakistan. For prescriptions or inquiries, contact sales@derma.pk or WhatsApp +92-320-5999650.

Usage & Benefits

- Helps control high blood sugar in Type 2 diabetes effectively.
- Improves insulin response and reduces glucose production in the liver.
- Provides better fasting and post-meal sugar control.
- Reduces the risk of diabetic complications such as nerve or kidney damage.
- Supports overall metabolic health and energy balance.

How To Use

1. Take Admit 50/500mg Tablets orally with meals to reduce stomach discomfort.
2. Swallow the tablet whole with a glass of water — do not crush or chew.
3. Follow your doctor's prescribed dosage carefully for optimal blood sugar control.
4. Continue regular monitoring of blood glucose levels during treatment.
5. Maintain a balanced diet and exercise routine alongside medication.

FAQs

What is Admit 50/500mg used for?

It is used to manage Type 2 diabetes by controlling high blood sugar through the combined action of Sitagliptin and Metformin. Prescription required.

How do Sitagliptin and Metformin work together?

Sitagliptin increases insulin secretion, while Metformin reduces glucose production and improves insulin sensitivity for comprehensive control.

How long should I take Admit Tablets?

Use as long as prescribed by your doctor — diabetes management is typically a long-term treatment requiring regular monitoring.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
Rs. 450